Xcout Intel
Cresilon, Inc.
Cresilon is a privately held medical device company that develops advanced hemostatic gel technology designed to control bleeding in seconds and improve wound care. Founded and headquartered in Brooklyn, New York, the company also operates its own GMP manufacturing facilities.
Subscribe to see Cresilon, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cresilon, Inc. at a glance
Cresilon, Inc. is a medical devices company headquartered in United States. Its most recent funding round raised $29M in April 2026. Xcout tracks 4 named people at Cresilon, Inc., including Scott Levine (Chief Financial Officer). Xcout recorded 10 job postings from Cresilon, Inc. in the last 90 days.
Cresilon, Inc. leadership
- Scott LevineChief Financial Officer
- Joe LandolinaCEO and Co-Founder
- Scott LevineExecutive Officer
- Isaac MillerDirector
Cresilon, Inc. funding rounds
The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $29M | — | |
| SEC Form D filing | $6.7M | — | |
| SEC Form D filing | $17.2M | — | |
| SEC Form D filing | $25M | — | |
| SEC Form D filing | $17.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Cresilon, Inc.
Xcout recorded 10 job postings from Cresilon, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Cresilon, Inc.'s hiring signals →
Investors
Tech stack
Cresilon, Inc. competitors
A few of Cresilon, Inc.'s closest competitors — see the full list of competitors and alternatives →
OptMed, Inc. is a privately held medical device company based in New York, New York, engaged in developing skin protectants and surgical sealants.
Beeken BioMedical is a medical device company that develops and commercializes advanced hemostatic wound care products, including the NuStat line of surgical dressings. The company serves first responders, military personnel, and healthcare providers by offering products designed to rapidly control severe bleeding and establish hemostasis.
Compression Works Inc. is a medical device company headquartered in Birmingham, Alabama, that develops and manufactures hemorrhage control solutions such as the Abdominal Aortic and Junctional Tourniquet.
Cerus Corporation operates as a biotechnology firm dedicated to advancing and marketing the INTERCEPT Blood System. This proprietary technology significantly enhances the safety of transfusable blood components by neutralizing biological threats, thereby reducing the risk of blood-borne pathogens. The company's product line includes INTERCEPT systems specifically engineered to deactivate pathogens in donated platelets and plasma. It also offers a dedicated INTERCEPT Blood System for the inactivation of harmful agents in red blood cell components. Furthermore, Cerus markets an INTERCEPT Blood System for Cryoprecipitation, which leverages its plasma technology to produce two key pathogen-reduced blood products: a cryoprecipitated fibrinogen complex for treating and controlling bleeding, particularly massive hemorrhages stemming from fibrinogen deficiency, and pathogen-reduced, cryoprecipitate-reduced plasma. Cerus distributes these platelet and plasma systems globally through a combination of its direct sales force and an extensive network of distributors, reaching markets in North America, Europe, the Commonwealth of Independent States, the Middle East, and Latin America. Established in 1991, Cerus Corporation maintains its corporate headquarters in Concord, California.
Belmont Technology Inc. designs and manufactures medical devices specializing in blood and fluid warming, temperature management, and hyperthermia solutions. The company serves clinicians and healthcare facilities across various critical care settings, including trauma, emergency, surgical care, and military applications.
BioWound Solutions, LLC provides advanced wound management products and dressings, including collagen technologies, antimicrobial protections, and moisture-balancing solutions. The company serves healthcare providers, clinicians, and organizations by supplying medical products designed to promote wound healing and clinical efficiency.
Get Cresilon, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Cresilon, Inc. in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- 10 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access